Indica
Backed by cutting edge technology, an uncompromising focus on ease-of-use and dedicated customer service, Indica Labs’ software and services are being used to make vital discoveries in pathology labs and research organizations around the world.
+1 (505) 492 0979
sales: info@indicalab.com
support: support@indicalab.com

Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1, Upcoming Webinar Hosted by Xtalks

Indica Labs / Events  / Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1, Upcoming Webinar Hosted by Xtalks

Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1, Upcoming Webinar Hosted by Xtalks

Join Daniel Sutton, Senior Scientist, Digitisation and AI, Clinical Pharmacology and Safety Science at AstraZeneca for an informative session about AI-based models in the quantification of pathology images. There will be two live broadcasts, on Monday, May 11, 2020 at 11am EDT (4pm BST/UK) and Tuesday, May 12, 2020 at 9am BST/UK.

Artificial intelligence (AI) is revolutionizing drug discovery and development to help scientists make data-driven decisions faster and more efficiently. Pathology is no exception and the Pathology Sciences team at AstraZeneca in Cambridge UK is leading the way. At AstraZeneca, Indica Labs’ HALO AI and other AI solution platforms are being used to examine digital pathology images for specific tissue classes, features and pathologies that are not easily quantified using traditional image analysis techniques or are too time-consuming for pathologists to quantify by eye.

While AI holds great promise in digital pathology, it is key to understand both the advantages and limitations of the technology, the technical requirements for different deployments and financial practicalities. In this one-hour webinar, Daniel Sutton will address these key points and will describe specific-use cases where AI has benefited pathology assessments and improved efficiency within his group at AstraZeneca. Prior to the main presentation, Dr. Kate Lillard Tunstall, Chief Scientific Officer at Indica Labs, will give a brief introduction to Indica Labs’ HALO AI solution.

Join this free webinar to learn more about cutting edge AI solutions in pathology image analysis.

To view the recording for this event, visit Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

About Indica Labs

Indica Labs is the world’s leading provider of computational pathology software and services. Our flagship HALO® image analysis platform enables fast, quantitative evaluation of tissues using a broad range of artificial intelligence (AI) and computer vision algorithms. HALO Link™ and HALO AP™ facilitate remote image analysis, collaboration and management. Through a combination of precision, performance, scalability, and usability our software solutions enable pharmaceutical companies, diagnostic labs, research organizations, and Indica’s own contract pharma services team to advance tissue-based research, clinical trials, and diagnostics.